Tectonic Therapeutic (TECX) Non-Current Deffered Revenue (2017 - 2022)
Tectonic Therapeutic (TECX) reported Non-Current Deffered Revenue of $10000.0 for Q3 2022, down 88.89% year-over-year from $90000.0 in Q3 2021, and down 16.67% quarter-over-quarter from $12000.0 in Q2 2022.
Tectonic Therapeutic (TECX) Non-Current Deffered Revenue (2017 - 2022) Analysis & Trends
Tectonic Therapeutic (TECX) has 6 years of Non-Current Deffered Revenue data on file, last reported at $10000.0 in Q3 2022.
- Non-Current Deffered Revenue for Q3 2022 came in at $10000.0, down 88.89% year-over-year; the trailing twelve-month figure through Sep 2022 was $10000.0 (down 88.89% YoY), and the FY2021 annual result was $30000.0, down 89.13% from the prior year.
- Non-Current Deffered Revenue slipped to $10000.0 in Q3 2022 per TECX's latest filing, from $12000.0 in the prior quarter.
- Over five years, Non-Current Deffered Revenue peaked at $781000.0 in Q2 2018 and troughed at $10000.0 in Q3 2022.
- A 5-year average of $340722.2 and a median of $303500.0 in 2020 frame the typical range for Non-Current Deffered Revenue.
- The sharpest annual moves came in 2018 and 2022: Non-Current Deffered Revenue surged 446.83% in 2018, then slumped 92.0% in 2022.
- A 5-year view of Non-Current Deffered Revenue shows it stood at $689000.0 in 2018, then slumped by 68.94% to $214000.0 in 2019, then rose by 28.97% to $276000.0 in 2020, then sank by 89.13% to $30000.0 in 2021, then sank by 66.67% to $10000.0 in 2022.
- Business Quant data shows TECX's Non-Current Deffered Revenue at $10000.0 in Q3 2022, $12000.0 in Q2 2022, and $30000.0 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Tectonic Therapeutic | 528.16 Mn | 291.27 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 10,000.00 |
| Jun 30, 2022 | 12,000.00 |
| Mar 31, 2022 | 30,000.00 |
| Dec 31, 2021 | 30,000.00 |
| Sep 30, 2021 | 90,000.00 |
| Jun 30, 2021 | 150,000.00 |
| Mar 31, 2021 | 214,000.00 |
| Dec 31, 2020 | 276,000.00 |
| Sep 30, 2020 | 331,000.00 |
| Jun 30, 2020 | 370,000.00 |
| Mar 31, 2020 | 430,000.00 |
| Dec 31, 2019 | 214,000.00 |
| Sep 30, 2019 | 535,000.00 |
| Jun 30, 2019 | 590,000.00 |
| Mar 31, 2019 | 645,000.00 |
| Dec 31, 2018 | 689,000.00 |
| Sep 30, 2018 | 736,000.00 |
| Jun 30, 2018 | 781,000.00 |
| Dec 31, 2017 | 126,000.00 |